This inventor holds 2 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 1991-2002.
Company Filing History:
Years Active: 1991-2002
Title: The Innovative Contributions of William M Snyder
Introduction
William M Snyder is a notable inventor based in New London, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of agents for the treatment of emesis. With a total of 2 patents to his name, Snyder's work has had a meaningful impact on medical science.
Latest Patents
One of Snyder's latest patents focuses on pharmaceutical agents for the treatment of emesis. This invention relates to a novel process for preparing and resolving 3-amino-2-phenylpiperidine. It also involves synthesizing certain pharmaceutically active substituted 2-phenyl-3-benzylaminopiperidines from the enantiomers of this compound. The substituted 2-phenyl-3-benzylaminopiperidines that can be prepared through this process serve as substance P receptor antagonists. These compounds are useful in treating and preventing inflammatory and central nervous system disorders, among other conditions.
Career Highlights
Snyder is currently associated with Pfizer Corporation, a leading pharmaceutical company. His work at Pfizer has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His innovative approaches have positioned him as a key figure in the field.
Collaborations
Throughout his career, Snyder has collaborated with several esteemed colleagues, including Harry A Watson, Jr and Glenn E Wilcox. These collaborations have further enhanced the quality and impact of his work.
Conclusion
William M Snyder's contributions to pharmaceutical innovation demonstrate his commitment to improving medical treatments. His patents and collaborations reflect a dedication to advancing healthcare solutions.